Literature DB >> 23096699

Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center.

Wei Xu1, Xiang Li, Wending Huang, Yu Wang, Shuai Han, Su Chen, Leqin Xu, Xinghai Yang, Tielong Liu, Jianru Xiao.   

Abstract

BACKGROUND: Giant cell tumor (GCT) of the mobile spine is a benign tumor, but it can be potentially aggressive. There is not much published information on GCT of the mobile spine as a result of rarity of the disease, and there are controversies over prognostic factors of the condition.
METHODS: A retrospective analysis of GCT of the mobile spine was performed by survival analysis. Recurrence-free survival (RFS) was defined as the interval between the date of surgery and the date of recurrence. The postoperative RFS rate was estimated by the Kaplan-Meier method. Factors with P values of ≤0.1 were subjected to multivariate analysis for RFS by proportional hazard analysis. P values of ≤0.5 were considered statistically significant.
RESULTS: A total of 102 patients with GCT of the mobile spine were included in the study. The mean follow-up period was 39.9 (median 26.0, range 2-153) months. Thirty-eight patients developed recurrence. The univariate and multivariate analysis suggested that age less than 40 years, total spondylectomy either by en bloc or piecemeal method, and administration of bisphosphonate were independent favorable prognostic factors. Subgroup analysis by excluding patients before the year 2000 further confirmed our findings.
CONCLUSIONS: The removal of the entire osseous compartment either by en bloc or piecemeal method in combination with the long-term use of bisphosphonate could significantly reduce the recurrence rate of GCT of the mobile spine. Age less than 40 years is a favorable prognostic factor for GCT in the mobile spine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23096699     DOI: 10.1245/s10434-012-2707-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  30 in total

1.  Treatment and outcome of malignant giant cell tumor in the spine.

Authors:  Huabin Yin; Mo Cheng; Bo Li; Binbin Li; Peng Wang; Tong Meng; Jing Wang; Wang Zhou; Wangjun Yan; Jianru Xiao
Journal:  J Neurooncol       Date:  2015-06-04       Impact factor: 4.130

Review 2.  Denosumab in the treatment of giant cell tumor of the spine. Preliminary report, review of the literature and protocol proposal.

Authors:  Stefano Boriani; Riccardo Cecchinato; Fabrizio Cuzzocrea; Stefano Bandiera; Marco Gambarotti; Alessandro Gasbarrini
Journal:  Eur Spine J       Date:  2019-05-16       Impact factor: 3.134

3.  Treatment and outcome of primary aggressive giant cell tumor in the spine.

Authors:  Huabin Yin; Xinghai Yang; Wei Xu; Binbin Li; Bo Li; Ting Wang; Tong Meng; Peng Wang; Tielong Liu; Wang Zhou; Jianru Xiao
Journal:  Eur Spine J       Date:  2015-01-29       Impact factor: 3.134

4.  Treatment options and prognosis for repeatedly recurrent giant cell tumor of the spine.

Authors:  Yifei Ma; Jialin Li; Jun Pan; Wangjun Yan; Quan Huang; Tielong Liu; Xinghai Yang; Cheng Yang; Wei Xu; Haifeng Wei; Jianru Xiao
Journal:  Eur Spine J       Date:  2016-03-17       Impact factor: 3.134

Review 5.  The clinical approach toward giant cell tumor of bone.

Authors:  Lizz van der Heijden; P D Sander Dijkstra; Michiel A J van de Sande; Judith R Kroep; Remi A Nout; Carla S P van Rijswijk; Judith V M G Bovée; Pancras C W Hogendoorn; Hans Gelderblom
Journal:  Oncologist       Date:  2014-04-09

Review 6.  Axial giant cell tumor - current standard of practice.

Authors:  Navaneeth Kamath; Jasmine Agarwal; Ashish Gulia
Journal:  J Clin Orthop Trauma       Date:  2019-10-09

7.  Malignant peripheral nerve sheath tumor (MPNST) in the spine: a retrospective analysis of clinical and molecular prognostic factors.

Authors:  Ting Wang; Huabin Yin; Shuai Han; Xinhai Yang; Jing Wang; Quan Huang; Wangjun Yan; Wang Zhou; Jianru Xiao
Journal:  J Neurooncol       Date:  2015-01-20       Impact factor: 4.130

8.  Giant cell tumor of the thoracic spine causing acute paraplegia-a case report.

Authors:  Christopher Lucasti; Dil Patel; Bradley Hawayek; Mark Maraschiello; Joseph Kowalski
Journal:  J Spine Surg       Date:  2021-06

9.  Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center.

Authors:  Tong Meng; Huabin Yin; Bo Li; Zhenxi Li; Wei Xu; Wang Zhou; Mo Cheng; Jing Wang; Lei Zhou; Xinghai Yang; Tielong Liu; Wangjun Yan; Dianwen Song; Jianru Xiao
Journal:  Neuro Oncol       Date:  2014-12-08       Impact factor: 12.300

10.  Total spondylectomy for Enneking stage III giant cell tumor of the mobile spine.

Authors:  Noriaki Yokogawa; Hideki Murakami; Satoru Demura; Satoshi Kato; Katsuhito Yoshioka; Takaki Shimizu; Norihiro Oku; Ryo Kitagawa; Hiroyuki Tsuchiya
Journal:  Eur Spine J       Date:  2018-09-12       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.